Nasal chondrocytes (NCs) have gained increased recognition for cartilage tissue regeneration. To assess NCs as a source for cell therapy treatment of intervertebral disc (IVD) degeneration, tissue-forming properties of NCs under physiological conditions mimicking the degenerated IVD were compared to those of mesenchymal stromal cells (MSCs) and articular chondrocytes (ACs), two cell sources presently used in clinical trials. Cells were cultured in a combination of low glucose, hypoxia, acidity and inflammation for 28 d. Depending on the conditions, cells were either cultured in the absence of instructive growth factors or underwent chondrogenic instructional priming by addition of transforming growth factor β1 (TGFβ1) for the first 7 d. Histology, immunohistochemistry, biochemistry, enzyme-linked immunosorbent assay (ELISA) and quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR) analyses demonstrated limited cell maintenance and accumulation of cartilaginous extracellular matrix for MSCs in IVD conditions. ACs maintained a steady accumulation of glycosaminoglycans (GAGs) throughout all non-acidic conditions, with and without priming, but could not synthesise type II collagen (Col2). NCs accumulated both GAGs and Col2 in all non-acidic conditions, independent of priming, whereas MSCs strongly diminished their GAG and Col2 accumulation in an inflamed environment. Supplementation with inflammatory cytokines or an acidic environment affected NCs to a lower extent than ACs or MSCs. The data, overall indicating that in an inflamed IVD environment NCs were superior to ACs and MSCs, encourage further assessment of NCs for treatment of degenerative disc disease.
Introduction
Lower back pain affects more than 600 million people globally, being the leading disability worldwide (Vos et al., 2012) . Intervertebral disc (IVD) degeneration is the most common cause of specific lower back pain (de Schepper et al., 2010; Luoma et al., 2000) . The IVD is a symphysis between two vertebral bodies and is the largest non-vascularised structure in the human body. It consists of a central hydrophilic proteoglycan-rich gelatinous core, the nucleus pulposus (NP), which is surrounded by a collagenous ring, the anulus fibrosus. The disc is separated from the vertebrae by a superior and inferior cartilage endplate (Roberts et al., 2006) . Degenerative disc disease (DDD) is caused by an imbalance of anabolic and catabolic processes in NP cells, leading to a loss of extracellular matrix (ECM) and its dehydration (Sivan et al., 2014) . This change promotes altered biomechanical loading and provokes inflammation, as well as structural damage to the annulus fibrous, which in turn can lead to pain (Adams and Roughley, 2006) . Despite known outcomes, approaches to treat or prevent further DDD are limited and surgery is required. Currently, surgical treatments resect structural damages, fuse the motion segments or perform total disc arthroplasty with the aim of removing the possible source of pain and restore biomechanical function. However, these procedures may promote degeneration of IVDs of neighbouring segments (Siepe et al., 2014) . For this reason, treatments dedicated to restoring IVD homeostasis are greatly in demand, one of which is cell therapy. As Vedicherla and Buckley (2017) indicated, the ideal cell source for IVD regeneration should meet the following criteria: (i) being autologous, (ii) being easily accessible, (iii) providing sufficient cell yield, (iv) producing equivalent disc-like ECM in the absence of exogenous growth factor supplementation, (v) sustaining the harsh microenvironment of the IVD.
The present cell source gold standard for DDD therapy is autologous mesenchymal stromal cells (MSCs), isolated either from bone marrow or adipose tissue (Pennicooke et al., 2016) . These cells have been favoured due to their accessibility and proliferative capacity. To date, the assumption for the lack of success of clinical trials in which MSCs have been employed for DDD treatment Huang et al., 2014; Naqvi and Buckley, 2016) is that the injected MSCs do not adapt or even survive for a reasonable time in the exceptionally harsh environment of a progressively degenerating disc. The IVD environment is acidic (Urban, 2002) and has low concentrations of glucose and oxygen . Upon DDD, the environment becomes inflamed (Risbud and Shapiro, 2014) , in addition to becoming more acidic (Ichimura et al., 1991) . For this reason, other, more committed cell sources, such as articular chondrocytes (ACs) or NP cells, which are prone to survive harsher conditions, were also evaluated as possible cell sources for DDD therapy (Pennicooke et al., 2016) . MSCs and ACs are two cell sources presently used in phase two clinical trials for the treatment of DDD (Pennicooke et al., 2016; Sakai and Andersson, 2015) . It may be argued that chondrocytes produce a more hyaline or fibrolike cartilage rather than the gelatinous matrix of the healthy NP. Nonetheless, it is conceivable that increasing disc height through matrix production of administered cells may counterbalance the progression of disc degeneration even if the matrix is not completely analogous to that of a healthy NP. A comparative in vivo preclinical study between MSCs and committed ACs demonstrated that ACs are superior to MSCs with regard to cell survival and ECM production (Acosta et al., 2011) . However, the harvesting of healthy autologous articular cartilage is difficult to consider, as an injury to a healthy joint would be required.
In recent years, nasal chondrocytes (NCs) have gained a reputation for cartilage tissue regeneration due to their robust cartilage-forming potential and adaptation capacity to the joint environment Mumme et al., 2016; Pelttari et al., 2014) . In addition, previous work (Candrian et al., 2008; Scotti et al., 2012; Vedicherla and Buckley, 2017) has shown the superiority of NCs over ACs in cartilage regeneration, even under inflammatory and load-bearing conditions. These reports have promoted the concept of investigating NCs for the treatment of DDD by means of supporting the accumulation of NP-like matrix (Tsaryk et al., 2015; Tsaryk et al., 2017; Vedicherla and Buckley, 2017) . One of the first steps for determining the potential of NCs as compared to other cell sources, which are at present most commonly used, is to test them in simulated IVD conditions before considering expensive and time-consuming preclinical models. Previously, in vitro experiments have been dedicated to analysing the behaviour of potential cell sources only within singular characteristics simulating the IVD environment. However, to determine the potential therapeutic value of NCs, it is necessary to analyse their behaviour in an in vitro setup mimicking various parameters of clinical conditions. With the goal of assessing whether NCs can be considered as a suitable cell source for cell therapy of DDD, the responses of NCs, in comparison to cell sources presently used in phase two clinical trials (i.e. MSCs and ACs) were investigated under in vitro hypoxic, low-glucose, acidic and inflamed conditions mimicking the physiological milieu of a degenerated IVD. In addition, a normoxic, high-glucose condition was included as a typical culture condition.
Materials and Methods

Cell harvest
Following informed consent and local ethical committee approval by the University Hospital Basel, Switzerland (reference number EK:78/07), human articular and nasal septal cartilage tissues were collected during autopsy from 3 individuals (2 male, 1 female, mean age 53 years, range 51-54 years), whereas bone marrow aspirates were obtained during routine orthopaedic procedures from the iliac crest of 3 donors (2 male, 1 female, mean age 24 years, range 17-30 years). NP tissue was acquired from 3 patients (2 male, 1 female, mean age 50 years, range 30-58 years) undergoing operations for lumbar spinal fusion [Pfirmann scale (Pfirrmann et al., 2001) of IVD of each patient was 2].
Cell isolation and culture
ACs and NCs were isolated by digestion with 0.15 % type II collagenase for 22 h and resuspended in Dulbecco's modified Eagle's medium (DMEM; 10938-015, Gibco) containing 4.5 mg/mL D-glucose and 0.1 mM non-essential amino acids and supplemented with 1 mM sodium pyruvate (11360-039, Gibco), 100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (15630-056, Gibco), 100 units/mL penicillin, 100 µg/mL streptomycin and 0.29 mg/mL L-glutamine (10378-016, Gibco) (basic medium). Chondrocytes were plated in tissue culture flasks at 1 × 10 4 cells/cm 2 and cultured for two to three passages in basic medium MHP Gay et al.
Nasal chondrocytes for degenerated disc repair supplemented with 10 % foetal bovine serum (FBS) (10270-106, Gibco), 1 ng/mL transforming growth factor (TGF) β1 (240-BO-10, R&D) and 5 ng/mL fibroblast growth factor 2 (FGF2; 233-FB-025, R&D), according to an established protocol . MSCs were isolated and expanded in minimum essential medium alpha modification (αMEM)-based basic medium supplemented with 5 ng/mL FGF2 for a total of two passages, according to an established protocol (Frank et al., 2002; Muller et al., 2009) . NP cells were isolated by digestion with 0.05 % type II collagenase for 22 h and resuspended in basic medium using DMEM: nutrient mixture F-12 (DMEM/F12; 21331-046, Gibco) supplemented with 5 ng/mL FGF2, according to the protocol described by Capossela et al. (2018) . Medium was changed twice a week.
Pellet culture model
Pellet culture of primary chondrocytes or MSCs was performed in 0.5 mL of DMEM, 1 mM sodium pyruvate, 100 mM HEPES buffer, 1 % insulintransferrin-selenium (51300-0449, Gibco), 0.56 % linoleic acid (L9530, Sigma-Aldrich), 0.14 % human serum albumin (43075, CSL Behring), 100 U/mL penicillin, 100 mg/mL streptomycin, 0.29 mg/mL L-glutamine, 0.1 mM ascorbic acid 2-phosphate (A-8960, Sigma-Aldrich) and 10 -7 M dexamethasone (D-2915, Sigma-Aldrich) (chondrogenic medium). For standard conditions, DMEM containing either 1 mg/mL D-glucose (31885-023, Gibco) and 0.1 mM non-essential amino acids (11140-050, Gibco) or 4.5 mg/mL D-glucose (10938-015, Gibco) was used. Acidic medium was prepared using 1 mg/L D-glucose DMEM powder (D5523, Gibco) dissolved in ddH 2 0 and pH was adjusted to 7 by using sodium bicarbonate. The media were prepared 24 h prior to medium change and placed into their respective incubators to allow for adjustment to the O 2 levels. 24 h incubation in hypoxia reduced the pH of standard media from 7.5 to 7.4 and acidic media from 7 to 6.8. For the establishment of this protocol, both acidic and O 2 levels were preliminarily assessed using the SDR SensorDish ® Reader Basic Set (Precision Sensing GmbH, Regensburg, Germany) in combination with the corresponding OxoDish ® and HydroDish ® plates. 250,000 cells were centrifuged in 1.5 mL conical polypropylene tubes (Sarstedt) to form spherical pellets (Muller et al., 2016) . In case of chondrogenic priming, medium was supplemented with 10 ng/mL TGFβ1 (240-BO-10, R&D) for the first 7 d. After a total of 4-week culture, pellets were processed as described below. For each experiment and experimental group, at least two replicate pellets per donor were assessed for each analysis. Medium was changed twice a week.
Biochemical assays
Generated tissues were digested for 16 h at 56 °C in proteinase K [1 mg/mL proteinase K (P2308, SigmaAldrich) in 50 mM Tris (A5456-3, Sigma-Aldrich) with 1 mM ethylenediaminetetraacetic acid (EDTA; 03680, Fluka), 1 mM iodoacetamide (I-1149, Sigma-Aldrich) and 10 mg/mL pepstatin A (P5318, Sigma-Aldrich)]. Glycosaminoglycan (GAG) content was determined spectrophotometrically using dimethyl methylene blue, with chondroitin sulphate as standard (Barbosa et al., 2003) . DNA content was measured using the CyQuant cell proliferation assay kit (Invitrogen), with calf thymus DNA as standard.
Collagen assays were performed using Sirius Red Total Collagen Detection Assay Kit (9062, Chondrex), Human type I Collagen ELISA detection Kit (6021, Chondrex) and Multi-Species Type II Collagen ELISA Detection Kit (6018, Chondrex). All three assays were performed on the same samples. Samples were solubilised and processed according to the manufacturer's instructions.
Quantitative real-time reverse transcriptasepolymerase chain reaction (qRT-PCR) Total RNA was extracted by combining the material of three replicate pellets. cDNA synthesis and qRT-PCR (7300, Applied Biosystems) were performed as previously described to quantify expression levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), Forkhead Box F1 (FoxF1), keratin 8 (KRT8), keratin 18 (KRT18), keratin 19 (KRT19), Paired Box 1 (PAX1), Sonic hedgehog (Shh), T Brachyury, T-box transcription factor T (T), ovolike zinc finger (OVO2), beta globin (HBB), hypoxiainducible factor (HIF), TGFβ1, TGFβ3, interleukin 1 receptor 1 (IL1R1), IL6 receptor (IL6R), tumour necrosis factor alpha receptor (TNFαR), collagen types I, II and X by using human-specific primers and probes (Barbero et al., 2006) (Hs02758991, Hs01595539, Hs02827483, Hs00761767, Hs00230962, Hs00196352, HS01123832, Hs00610080, Hs02384746, Hs00758889, Hs00153153, Hs000998133, Hs01086000, Hs00991010, Hs01075664, Hs01042313, Hs00164004, Hs00264051, Hs00166657, respectively, Applied Biosystems) . For each sample, Ct value of each target sequence was subtracted to Ct value of reference gene (human GAPDH, Hs02758991, Applied Biosystems) to derive the ΔCt.
Histology, immunohistochemistry and immunofluorescent histochemistry
After culture, pellets were fixed in 4 % paraformaldehyde, washed in PBS and embedded in Richard-Allan Scientific™ HistoGel™ Specimen Processing Gel (HG-4000-012, ThermoFisher Scientific), a hydroxyethyl agarose which is combined with other chemical reagents. Richard-Allan Scientific™ HistoGel™ Specimen Processing Gel was heated until in its liquid state, then retained at 65 °C using a water bath. Next, pellets were embedded in 30 µL gel droplets. The use of this gel allows a simplified retrieval and embedding in the desired orientation after dehydration and paraffinisation, without affecting sample, staining procedure or attaining of histological images. 4 µm-thick sections were cut (Microm HM 430 or Microm HM 340E) and www.ecmjournal.org slides were dehydrated prior to staining. Safranin-O/ fast green (SafO/FG; SafO: 84120, Sigma-Aldrich; FG: F-7252, Sigma-Aldrich) stain with haematoxylin (J.T. Baker) nuclear counterstaining was performed to analyse chondrogenic tissue formation. For immunohistochemistry, sections were subjected to enzymatic epitope retrieval at 37 °C first with 2 mg/ mL hyaluronidase (H3884, Sigma-Aldrich) and, then, with 1 mg/mL pronase (10165 921 001, Roche). After blocking the slides with 5 % bovine serum albumin, the following primary antibodies were used: rabbit anti-type I collagen (Col1) human-specific, 1 : 1000 (ab138492, Abcam); mouse anti-type II collagen (Col2), human-specific, 1 : 1000 (63171, clone II-4C11, MP Biomedicals). For immunofluorescence, immune-binding was detected with Alexa Fluor 488-or 564-conjugated secondary antibodies each at 1 : 500 (A21222 and A11030, Invitrogen, respectively) and DAPI was used as a nuclear counterstain. For immunohistochemistry, goat anti-mouse biotinylated secondary antibody 1 : 200 (E0433, Dako), VECTASTAIN ® ABC_AP Staining KIT (AK-5000, Vector Laboratories) and VECTOR ® Red Alkaline Phosphatase (Red AP) Substrate Kit (SK-5100, Vector Laboratories) were used for detection; haematoxylin was used as a counterstain.
Histology grading
Two observers evaluated pellet culture sections stained with SafO/FG using a light microscope (Olympus IX-83) and graded them using the Bern scor system (Grogan et al., 2006) . Both observers (2 basic scientists experienced in the examination of engineered cartilage) graded each sample blindly twice.
Statistical analysis
Two experimental replicates for each of the three donors (leading to a total of 6 experimental values) were used for the respective analysis. Each experimental replicate was based on the average of duplicate technical replicates. The results are Nasal chondrocytes for degenerated disc repair presented as mean ± standard deviation. Differences between experimental groups were assessed by two-way ANOVA with a Bonferroni's multiple comparison post-hoc test and considered statistically significant with p < 0.05 (Prism 7, Graph Pad Software).
Results
Cell responses to altered glucose and oxygen conditions
In a first simplified experimental setup mimicking the physiological IVD environment, influence of hypoxia and low-glucose were evaluated. MSCs, ACs and NCs were exposed to normoxia (20 % O 2 ) or hypoxia (2 % O 2 ) in either high (4.5 gr/L)-or low (1 gr/L)-glucose chondrogenic medium for 28 d in micro-mass culture. The impact of these conditions was assessed by cell maintenance and proliferation, ECM production and expression of cartilage-specific genes ( Fig. 1a ). For this first investigation, cells were cultured in the absence of the strong chondrogenic factor TGFβ1.
Comparison of DNA content by means of a biochemical assay of cell-pellets at day 28 versus day 0 (d0) revealed that MSCs significantly maintained only 34 % of their DNA contents in normoxic, highglucose conditions and between 65-75 % in the other conditions. Interestingly, ACs had a more than 10-20 % significant decrease in all conditions, whereas NCs displayed a trend to increase their DNA content by more than 10 % in all conditions (Fig. 2) . These results indicated a general superior tendency of NCs, as compared to the other cell sources, to survive/ proliferate.
Histological evaluation by SafO/FG stain revealed that there was no distinguishable GAG staining visible in MSCs in any condition (Fig. 3a , a.i-a.iv), with the exception of one donor in hypoxic, highglucose conditions (Fig. 3a, a. iii top). Although ACs did not accumulate sufficient GAGs to be observable in both normoxic conditions (Fig. 3a , a.v-a.vi), faint red staining could be noticed in the two hypoxic conditions (Fig. 3a , a.vii-a.viii). However, NCs displayed a weak GAG staining in both normoxic conditions (Fig. 3a , a.ix-a.x), similar to the one found in ACs in either hypoxic conditions. Additionally, NCs showed a distinctive colouring for GAGs in hypoxic conditions (Fig. 3a, a. xi-a.xii).
SafO/FG-stained sections were further graded using the Bern score, which accounts for uniformity and intensity of matrix staining, cell density/extent of matrix produced and cellular morphologies (Grogan et al., 2006) . The best scores for MSCs were found in the high-glucose conditions independent of the oxygen concentration. No statistically significant differences in total Bern score were observed between ACs and NCs. ACs and NCs significantly improved their overall score in hypoxic conditions, to the extent that in hypoxic, low-glucose conditions NCs significantly outranked MSCs. Additionally, in this condition, NC cell morphology was more rounded (Fig. 3b) than either MSCs or ACs (Table 1) .
Biochemical findings confirmed evaluations made by SafO/FG histology. Only cells from one of the three MSC donors produced a tissue which contained a relevant amount of GAGs (27.6 ± 4.25 µg/ pellet) in hypoxic, high-glucose conditions. This well-known donor variability of MSCs led to the differences between hypoxic, high-glucose conditions and the two low-glucose conditions [normoxic, low-glucose (Norm ↓Glu): p = 0.016; hypoxic, lowglucose (Hypo ↓Glu): p = 0.013]. Furthermore, cells from all MSC donors cultured in either of the low-glucose conditions resulted in a negligible GAG accumulation (≤ 1 µg/pellet). ACs showed limited GAG accumulation under all experimental conditions. Notably, NCs retained consistent GAG amounts in all conditions, with an exception in the hypoxic, high-glucose conditions, where NC pellets displayed a non-significant trend to accumulate more GAGs than in both normoxic conditions [normoxic, high-glucose (Norm ↑Glu): p = 0.28; Norm ↓Glu, p = 0.21] (Fig. 3c, c.i) . Based on the biochemical results, the three cell sources behaved similarly in all conditions, except hypoxic, high-glucose conditions, where MSCs and NCs accumulated significantly more GAGs than ACs (MSCs, p = 0.024; NCs, p = 0.028). However, even though no further significant difference was determined, histology and biochemical GAG determination indicated a trend towards more GAGs contained in the NC pellets in both low-glucose conditions (Fig. 3a, a. x, a.xii, and c, c.i).
Normalisation of GAG to DNA displayed no significant differences between cells in any of the four conditions. Nonetheless, an increase in GAG per DNA could be observed in hypoxic, high-glucose conditions for MSCs and NCs. Furthermore, it should be noted that in both high-glucose conditions, 
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MSCs displayed a higher GAG per cell ratio than either chondrocyte type. Additionally, NCs tended to accumulate slightly more GAGs per cell in lowglucose conditions than MSCs and ACs (Fig. 3c, c .ii). A feature of the NP is its high GAG to collagen ratio. The GAG to collagen ratio showed that MSCs and NCs in hypoxic, high-glucose conditions had a significantly higher ratio than ACs in the same condition, as well as their respective counterparts in both normoxic conditions. GAG to collagen ratio for MSCs in hypoxic, high-glucose condition was also significantly higher than in hypoxic, low-glucose conditions. The same comparison for NCs showed a non-significant decrease. Although no differences could be determined between the three cell types in normoxic, high-glucose conditions, NCs trended towards a higher GAG to collagen ratio than the other cell sources in the other three conditions (Fig. 3c, c. iii).
Immunohistochemistry for Col2 showed no detectable staining in either AC or MSC pellets in any of the conditions (Fig. 3d, d .i-d.viii), except for the same single MSC donor in hypoxic, low-glucose conditions, which also accumulated a considerable amount of GAGs (Fig. 3d d.iii top) . Notably, Col2 accumulated in NCs in all conditions (Fig. 3d,  d .ix-d.xii). However, in normoxic, low-glucose conditions, staining was rather weak. The comparison of accumulated Col2 versus accumulated Col1, as measured by enzyme-linked immunosorbent assay (ELISA), displayed that in hypoxic, high-glucose conditions, MSCs and NCs had the highest Col2/Col1 ratio in comparison to the other conditions. Moreover, clear trends towards higher Col2/Col1 ratio between NCs and MSCs or ACs were observed in all other conditions (Fig. 3e, e.i) .
Analysis of gene expression of COL2a1 was in accordance with immunohistochemistry. COL2a1 levels were not detectable for ACs in any of the four conditions. Gene expression of COL2a1 was detectable in NCs in all conditions except for lowglucose medium in normoxia (Fig. 3e, e. ii), in which Col2 staining was also the weakest.
COL1a1 expression levels remained consistent for all cell types from post-expansion d0 to differentiation at day 28, respectively, except hypoxic, low-glucose MSCs. These portrayed heightened levels due to the previously described chondrogenic outlier (Fig. 3e,  e. iii). Furthermore, mRNA for COL10a1 was only detected in MSCs under normoxic, low-glucose and hypoxic, high-glucose conditions (Fig. 3e, e.iv) .
In summary, the data reveal that in the absence of the chondrogenic growth factor TGFβ1, despite originating from different donors, only NCs were capable of producing consistently crucial ECM Hypo) were stained with SafO/FG and evaluated using the Bern score system, which accounts for uniformity and intensity of matrix staining, cell density/extent of matrix produced and cellular morphology. All criteria have equal weight separately evaluated on a scale of 0 to 3 and are added together (Total) with a possible minimum collective score of 0 and a maximum of 9. components of cartilaginous tissue in hypoxic, lowglucose conditions resembling those in the IVD to a higher degree than ACs or MSCs. However, the extent of chondrogenesis was generally weak in the absence of TGFβ1 supplementation; therefore, it could be speculated that the presence of such a growth factor induces cells to produce ECM that could protect them from the harsh environment of the degenerated IVD and, thus, probably improve ECM deposition in a therapeutic clinical approach.
The influence of chondrogenic priming in an in vitro model of a degenerated disc environment The complexity of the in vitro model was increased to more closely mimic the physiological environment of a degenerated disc, together with the application of the chondrogenic growth factor TGFβ1. The degenerated disc is not only a hypoxic, low-glucose environment but is also acidic and inflamed. The mildly degenerated disc environment is considered to have a pH of 6.8 (Gilbert et al., 2016; Naqvi and Buckley, 2016) and proinflammatory cytokines, such as TNFα, IL1β and IL6, are believed to be key mediators of disc degeneration by driving the catabolic cascades associated with the disease (Johnson et al., 2015; Molinos et al., 2015; Risbud and Shapiro, 2014) . To implement these conditions in vitro, in addition to the hypoxic, low-glucose conditions for 28 d, medium was adjusted to have a pH of 6.8 and/or the proinflammatory cytokines TNFα, IL1β and IL6 (100 pg/mL each) were supplemented to the medium. The concentrations were selected in the range of magnitude as found in patient pathological conditions (Akyol et al., 2010; Altun, 2016) . Considering that, in a therapeutic setup, growth factors would be injected into the disc only once with the cells and that these factors dissipate over time, TGFβ1 was only added for the first 7 d, which could be considered chondrogenic instructional priming (Fig. 1b) . In a preliminary assessment, primed cells in normoxic, high-glucose conditions were compared to cells continuously exposed to TGFβ1 throughout culture in the respective conditions to determine whether the 7 d priming would be sufficient to evoke the cell chondrogenic potential. SafO/FG stain and GAG quantification data indicated that 7 d TGFβ1 preculture was sufficient to promote ECM deposition by all cell types even if to a lower extent than 28 d. (Fig. 4) . However, 7 d of TGFβ1 priming were better than no TGFβ1 supplementation (Fig. 
4 vs. Fig. 3 ). For this reason, TGFβ1 priming was included in the pellet culture of cells exposed to the degenerated IVD conditions (Fig 1b) . To have a reference to the previous experimental setup, effects of priming were also analysed in hypoxic, low-glucose conditions without acidic medium or supplemented inflammation factors. Interestingly, priming in hypoxic, low-glucose conditions only induced production of cartilage matrix in the one MSC donor, who was also chondrogenic in hypoxic, high-glucose conditions without TGFβ1 (Fig. 5a, a.i, a.v top) . Nonetheless, the chondrogenic capacity of this donor was drastically reduced in the presence of proinflammatory cytokines (Fig. 5a, a. ii and a.vi). In both acidic conditions, MSCs did not condense to form a pellet and, thus, were not retrievable after 4 weeks (Fig. 5a, a. iii, iv, vii, viii).
Although a limited amount of GAG could be observed from ACs in all non-acidic conditions (Fig. 5b, b.i-b. ii), Col2 could not be distinguished by fluorescent immunohistochemistry in any of the four conditions (Fig. 5b, b .v-b.viii). Acidic conditions did not inhibit ACs from aggregating into pellets. However, GAG staining was not visible by SafO/ FG colouring (Fig. 5b, b. iii, b.iv). In contrast, NCs produced both GAGs and Col2 in all non-acidic conditions (Fig. 5c, c.i-c.ii, c.v-c.vi) . Moreover, NCs performed significantly better than MSCs in Bern score evaluation in the same conditions especially in the category "Cell Morphology", where NCs significantly outranked MSCs in hypoxic, lowglucose, standard, inflamed conditions (Table 3) . High magnification images show that well-formed lacunae were present in NC-engineered cartilage as compared to ACs (Fig. 5d) . As with ACs, NCs also aggregated into pellets in both acidic environments with no GAGs or Col2 observable by histology (Fig.  7c, c. iii, iv, vi, viii). Furthermore, no distinguishable (Table 3) .
Biochemistry for GAG content supported the findings of the histological analysis. Primed NCs and MSCs accumulated similar amounts of GAGs in normoxic, high-glucose conditions (Fig. 4b ) and in hypoxic, low-glucose conditions (Fig. 5e-e.i) . ACs accumulated less than either MSCs or NCs. Nonetheless, in hypoxic, low-glucose, inflamed conditions, ACs accumulated amounts of GAG comparable to NCs, whereas MSCs accumulated virtually none, being significantly different from both chondrocyte types (Fig. 5e, e.i) . In hypoxic, lowglucose, acidic conditions, GAG accumulation could only be detected in one AC donor ( Table 2) . None of the NCs accumulated the same amount of GAGs as this one donor; however, GAG accumulation could be measured for each donor ( Table 2) . When proinflammatory factors were added to this acidic environment, no GAGs could be detected from any AC pellet. Notably, however, NCs retained the same accumulation of GAGs as without inflammation factors in the respective conditions (Fig. 5e , e.i, Table  2 ).
GAG to DNA ratio showed no significant differences between all three cell types in either standard condition. However, a clear trend towards higher GAG per cell performance could be observed between either chondrocyte types and MSCs in hypoxic, low-glucose, inflamed conditions. Moreover, in acidic, non-inflamed conditions, both ACs and NCs had comparable GAG per cell performance, which NCs retained even in acidic, inflamed conditions (Table 2i) . Corresponding results for GAG to DNA ratio could also be observed for total accumulated GAG to total accumulated collagen ratio in the respective conditions. MSCs significantly reduced GAG to collagen ratio in standard, inflamed conditions as compared to standard, non-inflamed conditions. ACs retained a constant GAG to collagen ratio in both standard and Table 2 . Average accumulated GAGs in ACs and NCs donors in acidic conditions. n.d.: not detected.
acidic, non-inflamed conditions. Interestingly, ACs displayed a non-significant increase in their GAG to collagen proportion when cultured in the presence of inflammation factors in standard conditions. On the other hand, NCs displayed no changes in GAG to collagen ratio between inflamed and noninflamed standard conditions. However, the ratio was similarly reduced for both conditions when NCs were additionally cultured in an acidic environment (Fig. 5f, f.i) .
The comparison between the accumulated Col2 versus Col1 was similar in the three cell types in standard, non-inflamed conditions. Interestingly, in the presence of inflammation factors in standard conditions, MSCs and ACs retained a similar Col2 to Col1 ratio, whereas NCs had a trend towards an increased ratio. This increase led to a significant difference between NCs and the other two cell sources in the standard, inflamed conditions. However, this spike in performance was significantly altered when NCs were within an acidic environment, where they fell back to a similar Col2 to Col1 ratio to ACs (Fig.  5f , f.ii).
qRT-PCR for COL2a1 was consistent with the immunohistochemistry, only the one MSC donor, who was chondrogenic in hypoxic, high-glucose conditions, expressed Col2a1 in the standard, noninflamed conditions. Gene expression of Col2a1 could not be detected in ACs in standard, non-inflamed conditions. However, low detection was present in standard, inflamed conditions. Nonetheless, this was significantly lower than the Col2a1 gene expression of NCs in standard, inflamed conditions (Fig. 5g, g.i) . Gene expression for COL1a1 displayed no difference between the different cell sources in either standard condition. Although COL1a1 gene expression was significantly reduced for both chondrocytes from standard to acidic conditions, no differences were identified between ACs and NCs in the respective acidic conditions (Fig. 5g, g.ii) .
Even though MSCs could be primed for chondrogenesis, harsh environmental conditions and donor variability played a crucial role in their successful chondrogenesis and survival. ACs were sensitive to priming in that they could accumulate GAGs. Even though ACs had comparable Col2 vs. in normoxia (Norm) condition or in low-glucose (↓Glu) and hypoxia (Hypo) conditions combined with either standard (pH 7.4) or acidic (pH 6.8) medium, with (Inf) or without (no Inf) the proinflammatory factors TNFα, IL1β and IL6 and with the supplementation of TGFβ1 for the first 7 d (+ 7 d TGFβ1). d0: day 0 of pellet culture. Levels are expressed as fold of difference from GAPDH. * p < 0.05; ** p < 0.01; *** p < 0.001; n.d.: not detected. www.ecmjournal.org Col1 ratio to NCs, they lacked the ability to express detectable amounts of COL2a1. Furthermore, in standard conditions, the addition of inflammation factors increased AC GAG to collagen ratio. Indeed, primed NCs produced ECM containing both GAG and Col2 in all non-acidic conditions. Even though an acidic environment reduced GAG accumulation in NCs, reproducible detection throughout donors was witnessed for both acidic conditions as opposed to ACs. GAG to collagen ratio in NCs was reduced in acidic conditions. However, they retained a steady state in both inflamed and non-inflamed acidic media. In addition, Col2 to Col1 accumulation was at its highest in standard, inflamed conditions and in a reduced steady state in both acidic conditions, similar to that of ACs. This indicated that, upon chondrogenic priming, NCs were considerably more resilient to a harsh IVD environment than MSCs and comparable, if not slightly more adept, to ACs.
Expression of inflammation-related factors
To address why ACs and NCs were less affected than MSCs by proinflammatory cytokines in nonacidic conditions, the expression of the receptors for the corresponding factors were investigated. Surprisingly, mRNA expression of TNFαR, IL6R and IL1R1 was not significantly different for cell sources in same conditions, except for in hypoxic, low-glucose, standard, non-inflamed conditions (Fig. 6a,b,c) . In these circumstances, NCs displayed a significantly higher level of IL1R1 and TNFαR gene expression in comparison to ACs and MSCs. However, these increases in mRNA expression, when compared to cells at d0, were not observed in either inflamed or acidic conditions or in a combination of both (Fig.  6a,b,c) . Interestingly, gene expression of TNFαR and IL1R1 in NCs was down-regulated in acidic, inflamed conditions as compared to standard, noninflamed conditions. However, gene expression of the two receptors was increased as compared to cells post-expansion at d0 and primed cells cultured in normoxic, high-glucose conditions. A further variance could be observed in ACs in standard, non-inflamed conditions, where cells displayed a statistically significant higher expression of IL6R as compared to MSCs. Moreover, IL6R expression increased upon post-expansion culture in all conditions as compared to d0. However, such an increase was statistically significant only in normoxic, high-glucose conditions.
Gene expression of the multifunctional cytokines TGFβ1 and TGFβ3, which promote chondrogenesis, was quantified. ACs and NCs retained a constant TGFβ1 expression in all culture conditions after 28 d as after expansion, whereas MSCs had increased TGFβ1 expression levels when primed and cultured in normoxic, high-glucose conditions. However, when MSCs were cultured in hypoxia with low glucose, they displayed the same level of expression as at d0 Nasal chondrocytes for degenerated disc repair (Fig. 6d) . TGFβ3 gene expression was significantly higher in ACs than in MSCs and NCs prior to culture at d0. ACs retained a stronger gene expression than MSCs in primed normoxic, high-glucose, as well as in hypoxic, low-glucose, standard, noninflamed conditions. Nonetheless, ACs had reduced expression of TGFβ3 mRNA in an inflamed or acidic environment. Primed NCs had a similar TGFβ3 expression in all displayed conditions as compared to d0 cells. In any of the primed hypoxic, low-glucose conditions, gene expression in NCs was comparable to that in ACs (Fig. 6e) .
Screening for varied expression of NP markers in the different cell sources
Many studies have compared gene expression in ACs to NP cells to distinguish and identify NP specific genotypic markers, which could contribute to physiologic consequences and dictate NP cell function (Lv et al., 2014; Risbud et al., 2015; RodriguesPinto et al., 2013) . Based on these studies, the markers Krt8, Krt18, Krt19, T, FoxF1, Pax1, Shh, Ovo2, HBB and HIF were selected and qRT-PCR screening was performed on MSCs, ACs, NCs and NP cells cultured in hypoxic, low-glucose conditions with TGFβ1 supplementation. The markers Pax1, Shh and Ovo2 could not be detected in any cell type. Expression of Krt18, HBB and HIF was similar in all four cell types as they displayed no trends or significant changes. Expression of Krt8, Krt19 and T was detected to a lower extend, if at all, in the three cell therapy sources as compared to NP cells. Overall, gene expression of all measured markers in the three cell sources was similar (no statistically significant variation), with the exception of the transcription factor FoxF1 (Fig. 7a) . Further analysis of this marker in all the tested conditions showed that at d0 expression of FoxF1 was just above the level of detection in NCs and not detectable in ACs nor MSCs. After 28 d of pellet culture, NCs displayed a maintenance or a non-significant increase in FoxF1 gene expression in all conditions without TGFβ1 and standard, primed conditions (Fig. 7b) . These data indicated that, in respect to the chosen markers, NCs cultured in micromass shared a joint marker with NP cells.
Discussion
MSCs are the cell source analysed most frequently in conditions resembling the environment of an IVD , as they are the most commonly used cell source for DDD cell therapy. However, most reports have only investigated one or two facets of the degenerating IVD. The presented work was the first to compare MSCs, ACs and NCs in identical conditions representing multiple physiological characteristics of the degenerated disc environment. The results showed that in hypoxic, low-glucose and growth-factor-free culture conditions, NCs were superior to both MSCs and ACs in survival, proliferation and reproducible ECM accumulation. In respect to MSC behaviour, results were consistent with previous studies (Kanichai et al., 2008; Risbud et al., 2004) . Recently, Versicherla and Buckley (2017) have performed a similar study in which they have compared the performance of alginateencapsulated bovine NCs and ACs cultured with low-glucose medium in either normoxia or hypoxic (5 % O 2 ) conditions with and without TGFβ3 supplementation. In line with their growth factor-free results, the present study observations supported the eminence of NC capabilities in hypoxic, lowglucose conditions. Moreover, the degenerated disc environment has further harsh characteristics, such as acidity and inflammation. Cell potency could be increased through TGFβ supplementation. Although continuous TGFβ supplementation would not be foreseen in a therapeutical setting, a cell treatment could be initiated in combination with the delivery of growth factors. A follow-up experiment with chondrogenesis-primed cells in hypoxia, lowglucose, acidic and inflamed conditions indicated that NCs were more liable to reproducibly endure a degenerated IVD environment and accumulate ECM, as measured GAG levels were equal or higher than that of MSCs or ACs. Additionally, NCs were the only cell source to accumulate sufficient Col2 in standard, inflamed conditions to be detected by immunohistochemistry. Despite these encouraging outcomes were in line with previous studies, it should not be neglected that ECM component values were not in the same range of magnitude as native tissue or previous studies. Cell therapy for treating DDD is mainly aimed at re-establishing the balance of anabolic and catabolic processes regulating NP matrix maintenance. It is logical to favour a cell source which can accumulate a similar, if not equal, amount of ECM as a healthy NP. Native healthy NP tissue has a unique biochemical composition with a GAG to collagen ratio of 27 : 1 . For all three tested cell types, results generated under the described conditions did not come close to this ratio. GAG to collagen ratio was also not comparable to that measured by Vedicherla and Buckley (2017) , who performed similar experiments with bovine ACs and NCs in alginate hydrogel. The use of hydrogels, scaffolds or micro-carriers, as well as the seeding density within such constructs, can influence cell re-differentiation and ECM accumulation (Lee et al., 2017; Miao et al., 2018) . The aim of the present study was to compare the individual potency of the three cell sources independent of a scaffold material. IVD degeneration process is believed to be initiated by the dehydration of the NP caused by the reduced synthesis of GAG matrix. Cell concentration declines progressively, leading to further decline in matrix turnover, not just in the NP, but also in the annulus fibrosus, which becomes thickened and may develop radial fissures (Rea et al., 2012) . Injection of cells that survive and accumulate cartilaginous matrix in the hostile IVD www.ecmjournal.org environment could slow down or even halt the progression of DDD and possibly its associated pain in patients diagnosed in early stages. It has not been proven that this matrix has to be analogous to that of a healthy NP tissue in terms of quality and abundance. It stands to reason that a divergent matrix accumulated and maintained by injected cells could inhibit disc height loss, compression stress on the annulus fibrosus and its thickening. Nonetheless, although the matrix produced by all three cells sources was more akin to hyaline or fibrocartilage, the matrix synthesised by NCs was still more similar to that of the NP than those synthesised by ACs and MSCs. Aside from their matrix-forming capacity, an increase in DNA content in NC constructs could be observed, which suggested their capability to proliferate even in a low-nutrient IVD environment. An increase in cell number is desirable to the extent where the proliferation of injected cells could compensate for the continued loss of native resident NP cells. In vivo investigations are planned to determine survival and proliferative capacity of NCs in an IVD, whether NC-accumulated matrix is sufficient to compensate for the loss of the actual NP tissue, and to ascertain whether the potential of NC matrix synthesis could be optimised with a suitable carrier material.
Although both NCs and ACs were committed chondrocytes and both survived in the harsh conditions better than MSCs, NCs displayed increased DNA content and ECM accumulation as compared to ACs. Mechanisms which could explain the differences between the two chondrocyte types are still unclear but could be related to the lack of peroxisome proliferator-activated receptor (PPAR) signalling in NCs, which restricts TGFβ signalling in ACs (do Amaral et al., 2012) . The robustness of NCs has also been attributed to their developmental origin. Articular cartilage is a derivative of the mesoderm, whereas nasal cartilage derives from cranial neural crest stem cells, which are of neural ectoderm origin (Santagati and Rijli, 2003) . Many studies have compared gene expression of ACs to NP cells to distinguish and identify NP-specific genotypic markers. The contribution and function of such markers to an NP phenotype remains unknown. However, it is speculated that they contribute to physiologic consequences and dictate NP cell function (Lv et al., 2014; Risbud et al., 2015; Rodrigues-Pinto et al., 2013) . Due to the difference in developmental origin, it was conceivable that there would also be differences in the expression of some of these markers between NCs and ACs. The expression levels of these markers were similar in MSCs, ACs and NCs, with one exception. The transcription factor FoxF1 was detected in NCs but not in ACs or MSCs, thus establishing a genetic similarity to NP cells. The precise functions of FoxF1 are still unknown, but FoxF1 is a downstream target of hedgehog signalling and is involved in cell growth and ECM regulation in anti-fibrotic pathways (Melboucy-Belkhir et al., 2014) .
It is tempting to speculate that FoxF1 contributed to the robustness required by NP cells to survive in the harsh IVD environment; however, this would need to be evaluated in further studies.
A preliminary attempt was taken at determining why ACs and NCs were less affected than MSCs by proinflammatory cytokines. An investigation of corresponding receptor gene expression did not lead to any conclusive finding. Nonetheless, NCs had an increased gene expression of TNFαR and IL1R1 in hypoxic, low-glucose, standard and non-inflamed conditions as compared to cells post-expansion. These levels were decreased in acidic and inflamed conditions. Thus, NCs had a different reaction to environmental cues on receptor expression than MSCs or ACs, which behaved similarly.
The most common cell source used in treating DDD by cell therapy is MSCs, due to their high proliferative ability, multilineage potential and immunomodulatory properties. However, MSCs also display many drawbacks, one of which is a wellknown donor variability (Eslaminejad et al., 2013; Kim et al., 2018) . Such a variability was observed also in the present study, with respect to chondrogenic potential. Results indicated that, beyond inter-donor variability, one challenge when using MSCs in IVD regeneration is their capacity to react to harsh conditions mimicking the IVD environment. In fact, even the most chondrogenic MSCs consistently displayed weakened ability to synthesise ECM the harsher the environment became, up to the point of probable cell death in acidic medium. MSC vulnerability to the environment at the implantation site has been observed in various studies on different tissues (Degano et al., 2008; Haider and Ashraf, 2008; Logeart-Avramoglou et al., 2010; Togel et al., 2008) . One of the harshest surroundings is found in the IVD, due to the IVD being the largest non-vascularised structure of the human body. Nevertheless, multiple clinical trials have attempted to inject MSCs into the disc with the purpose of tissue replacement, as MSCs are a convenient cell source (Sakai and Andersson, 2015) . Neither tissue replacement nor residing viable injected cells could be demonstrated in these studies. Even so, patients of the previously mentioned trials described pain lessening. This effect, also witnessed in MSC clinical studies for other tissues, is increasingly attributed to the paracrine activity of MSCs, MSCmediated transfer of organelles, as well as the transfer of molecules through MSC-derived extra-cellular vesicles (Spees et al., 2016) . These characteristics of MSCs have become so distinguishable to suggest the name of "Medicinal Signalling Cells" (Caplan, 2017) . In this regard, the study aim was not to discourage MSC consideration for DDD treatment but imply that direct tissue replacement or regeneration is not to be expected. Moreover, function and effect of transplanted MSCs as therapeutic drug delivery in situ through their exchange of bioactive factors need to be considered. Since this aspect was not within the scope of the study, further work will be necessary MHP Gay et al.
Nasal chondrocytes for degenerated disc repair to compare the potency of the different cell sources related to paracrine conditioning as an alternative mode of action. Previous studies have explored the chondrogenic capacity of MSCs and ACs and found that committed chondrocytes are more adept at making stable cartilaginous tissue (Acosta et al., 2011; Erickson et al., 2009; Fernandes et al., 2013; Kuh et al., 2009; Tew et al., 2008) . These findings would make ACs the preferable source for cell therapy of joint-related orthopaedic malignancies such as DDD and osteoarthritis. However, considering that to obtain autologous ACs, a biopsy of a healthy joint is required, which may initiate a degeneration in the respective joint, autologous ACs are less than ideal candidates. In addition, extensive laboratory-based expansion leads to dedifferentiation, which in turn requires growth factor supplementation to maintain or restore the AC phenotype (Gruber et al., 1997) . NCs, on the other hand, can be relatively effortlessly acquired from the septal cartilage under local anaesthetic without negative consequences to the source structure or donor site morbidity. Furthermore, NCs have improved capacity for ECM deposition as compared to AC in articular joint settings (Candrian et al., 2008; Kafienah et al., 2002; Pelttari et al., 2014; Scotti et al., 2012) . These findings and many others validating NCs for tissue-engineered cartilage constructs (Asawa et al., 2009; Chia et al., 2005; Hellingman et al., 2011; Malda et al., 2004; Richmon et al., 2005; Twu et al., 2014; Watson and Reuther, 2014) have aroused the interest to consider NCs for NP tissue regeneration (Tsaryk et al., 2015; Tsaryk et al., 2017) .
This was the first study to compare NCs to MSCs and ACs, which are presently being tested in clinical trials, in respect to their ECM-forming capacity under conditions modelled after a degenerated disc environment, as these are well known. NCs seemed to be a better choice for treatment of DDD than MSCs and ACs, as they could better produce ECM in an in vitro IVD environment, are easily attainable and have a good proliferative capacity. The study findings encourage the assessment of NCs in a cell therapy treatment of DDD to promote new matrix production in the IVD, which could inhibit or delay further IVD height loss if not even lead to height gain and repair. As this application was only recently recognised in this study, in vitro, in vivo characterisation of their performance in a degenerated disc environment is crucial.
